Select Page

FW: 8/11/2017 – 8Nov – TGA – Infections associated with heater-cooler devices

Home Forums Infexion Connexion FW: 8/11/2017 – 8Nov – TGA – Infections associated with heater-cooler devices

 | Click to Receive Email Notifications of Posts
Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #74159
    Glenys Harrington
    Participant

    Author:
    Glenys Harrington

    Position:
    Consultant

    Organisation:
    Infection Control Consultancy (ICC)

    State:

    Dear All,

    Find below a link to the TGA update on Infections associated with
    heater-cooler devices

    https://www.tga.gov.au/alert/infections-associated-heater-cooler-devices

    In summary:

    A total of six Australians have been confirmed with Mycobacterium
    chimaera infections following heart surgery involving heater-cooler devices

    The confirmed cases of infection are associated with contaminated
    Stckert Heater-Cooler 3T heater-cooler units that were manufactured before
    September 2014

    Testing of Stckert 3T Heater-Cooler System (3T) devices by
    hospitals in Australia has identified that 25% of these devices have tested
    positive for the Mycobacterium chimaera organism or other organisms. All
    devices that tested positive were manufactured prior to September 2014

    The TGA previously published advice regarding the potential for
    water within heater-cooler units to become contaminated with bacteria, most
    commonly non-tuberculous mycobacterium (NTM). There is evidence to suggest
    that patients are infected when bacteria in the device’s water tank becomes
    airborne

    The latest recall for production correction by LivaNova, published
    on the TGA Recall actions web site on 27 October 2017, is to install a
    modification that reduces the risk of potential patient infection by
    preventing dispersion of contaminated aerosols in the operating room:

    o This correction will be implemented by onsite modification of units
    currently in use

    o The servicing will be undertaken in the field by LivaNova service
    personnel or a local agent

    Although the potential for infection is less likely when the 3T
    devices water system is maintained according to the current Instructions
    for Use (IFU), the disinfectant required to undertake the maintenance is not
    currently included in the appropriate category of the Austrlian Register of
    therapeutic Goods (ARTG)

    Therefore, the TGA has suspended the supply of new 3T devices
    until the disinfectant can be suitably accessed to ensure adequate
    maintenance

    o The suspension of the 3Ts devices ARTG entry does not preclude
    LivaNova from undertaking the modifications to existing 3T devices

    o The 1T devices will be replaced with 3T devices as the 1T devices are
    unable to be modified to prevent aerosol dispersion

    I contacted Livanova PTY LTD who advised that the disinfectant going through
    the assessment process for registration with the TGA is a product called
    Minncare Cold Sterilant (22% Hydrogen peroxide w/w, Peracetic acid 4.5%). I
    have attached the safety data sheet.

    The registration assessment process may take some months.

    If you need more information you can contact Livanova PTY LTD and ask for
    the Service Department

    https://www.whitepages.com.au/livanova-australia-pty-limited-11933816/toowon
    g-qld-11933814B

    regards

    Glenys

    Glenys Harrington

    Infection Control Consultancy (ICC)

    P.O. Box 6385

    Melbourne

    Australia, 3004

    M: +61 404816434

    E: infexion@ozemail.com.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #74161
    Michael Wishart
    Participant

    Author:
    Michael Wishart

    Position:

    Organisation:

    State:
    NSW

    Thanks Glenys, very useful.

    According to one of our perfusionists, Minncare has been available in Australia as a ‘cleaner’ (not TGA registered) for dialysis machines and HCUs for years now. It seems LivaNova is now getting TGA approval for its use as a disinfectant in their machines, so it has been withdrawn from the market until approval is obtained.

    Cheers
    Michael

    Michael Wishart
    Infection Control Coordinator

    A 627 Rode Road, Chermside QLD 4032
    P (07) 3326 3068 | F (07) 3607 2226 | E michael.wishart@svha.org.au | W http://www.hsnph.org.au
    [cid:image001.png@01D01926.61F1C2B0]
    P Please consider the environment before printing this email
    [https://www.safetyandquality.gov.au/wp-content/uploads/2017/11/AAW-2017-Signature-block.jpg]

    Dear All,

    Find below a link to the TGA update on Infections associated with heater-cooler devices

    https://www.tga.gov.au/alert/infections-associated-heater-cooler-devices

    In summary:

    A total of six Australians have been confirmed with Mycobacterium chimaera infections following heart surgery involving heater-cooler devices

    The confirmed cases of infection are associated with contaminated Stckert Heater-Cooler 3T heater-cooler units that were manufactured before September 2014

    Testing of Stckert 3T Heater-Cooler System (3T) devices by hospitals in Australia has identified that 25% of these devices have tested positive for the Mycobacterium chimaera organism or other organisms. All devices that tested positive were manufactured prior to September 2014

    The TGA previously published advice regarding the potential for water within heater-cooler units to become contaminated with bacteria, most commonly non-tuberculous mycobacterium (NTM). There is evidence to suggest that patients are infected when bacteria in the device’s water tank becomes airborne

    The latest recall for production correction by LivaNova, published on the TGA Recall actions web site on 27 October 2017, is to install a modification that reduces the risk of potential patient infection by preventing dispersion of contaminated aerosols in the operating room:

    o This correction will be implemented by onsite modification of units currently in use

    o The servicing will be undertaken in the field by LivaNova service personnel or a local agent

    Although the potential for infection is less likely when the 3T device’s water system is maintained according to the current Instructions for Use (IFU), the disinfectant required to undertake the maintenance is not currently included in the appropriate category of the Austrlian Register of therapeutic Goods (ARTG)

    Therefore, the TGA has suspended the supply of new 3T devices until the disinfectant can be suitably accessed to ensure adequate maintenance

    o The suspension of the 3T’s device’s ARTG entry does not preclude LivaNova from undertaking the modifications to existing 3T devices

    o The 1T devices will be replaced with 3T devices as the 1T devices are unable to be modified to prevent aerosol dispersion

    I contacted Livanova PTY LTD who advised that the disinfectant going through the assessment process for registration with the TGA is a product called Minncare Cold Sterilant (22% Hydrogen peroxide w/w, Peracetic acid 4.5%). I have attached the safety data sheet.

    The registration assessment process may take some months.

    If you need more information you can contact Livanova PTY LTD and ask for the Service Department
    https://www.whitepages.com.au/livanova-australia-pty-limited-11933816/toowong-qld-11933814B

    regards

    Glenys

    Glenys Harrington
    Infection Control Consultancy (ICC)
    P.O. Box 6385
    Melbourne
    Australia, 3004
    M: +61 404816434
    E: infexion@ozemail.com.au

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by returnhttps://clicktime.symantec.com/a/1/xTbRQx9G75ZMAeV4lXVFZ0JV4HeOh7UE-GEk_yL41lQ?dAvUohYvI4UhQ4DWR7S1VZYSv77wqGlIDelU3WRXme42xZCgHI0-iL4YFqw-lZsc2-SUKfjk6-_VXB71Hbexu7DekTuaH2cPmtdmZjIetzHn_q_TFD6EdzqlYYnVxr8VBOEXEBgUJ5l5Z-87UC_tZShxab6xCXgoWr4F1WuxScaJLewz7sMG3gxph50s0IEwQhjTTIhsWe1A2usdGKCGEUInFkB0Yh3eGnisORtDpabBkTBIbX_pLtuVRn9500s1n8Dqvss-PfecjgQrOzSExC6wcTf6VMmqUV6k3H4KZL5yq0b0W41uuA8Q9lGHucSkD4O1pwrz5N9vFXO_q2hq8a3NS-HMHvjBAVqb0x1XHcGjCAPtQzz3eArRp6L1mC4nNVajL8ReYYYOkpwxroGgr0MKxgpKs2eX58MszIg4LJ3WuXzr5BkI4SX_FqdvOIXHvwxGJeqdXoFCBjVGwK6urRVdwl0Ee4rkLgDk9fZSf4Kwekgq1K9NlvruvYL_VJX2keT2uI2bu7Kw4&uemail%2C%20delete%20the%20Email%2C%20and%20do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 2 posts - 1 through 2 (of 2 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.